7:00-7:30 AM Welcome and Introduction

7:30-8:30 AM
New Trends in Managing the AF Epidemic
Moderators:  Nassir Marrouche, MD and Mina Chung, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

The Role of GLP1 Agonists in Patients with Atrial Fibrillation
Donna Ryan, MD

GLP-1 Agonists & Epicardial Adipose Tissue: Impact on AF  
Gianluca Iacobellis, MD, PhD

Screening for AF: Differential Risk Factors and Outcomes for Asymptomatic vs. Symptomatic AF
Christine Albert, MD

Digital Health for AF Detection and Management: Boon or Bust?
Rod Passman, MD

Leveraging Novel Data Types to Estimate Atrial Fibrillation Risk
Shaan Khurshid, MD

Panel and Audience Discussion (25 minutes) - All Faculty and Natalia Trayanova, PhD

8:30-9:30 AM
Spotlight Session – New and Emerging Technologies in Arrhythmia Management
Moderator: Kenneth Ellenbogen, MD
All lectures 5 minutes. FDA Presentation 7 minutes.

AF Ablation Using a Novel Coherent Sine Burst Pulsed Field System: Acute and 90-Day Remapping Results (Arga Medtech)
Ante Anic, MD

First Clinical Experience with the BTL EasyPulz System for AF Ablation
(BTL Medical)
Vivek Reddy, MD

Esophageal Cooling During RF Ablation: Clinical Evidence and Workflow Considerations (Haemonetics)
Mark Metzl, MD

Cardio-Sleep Platforms to Co-Manage Sleep Apnea in Patients with AF (Huxley Medical)
Devi Nair, MD

Advanced 3D Navigation and Imaging for True Anatomical Guidance in a New Era of Cardiac Therapies (LumaVision)
Shephal Doshi, MD

Pulsed Field Ablation with Integrated Metabolic Feedback for Lesion Assessment and Gap Mapping (LuxMed Systems)
Timothy Maher, MD

Closed-loop Non-invasive Neuromodulation & Monitoring System for the Treatment of Atrial Fibrillation (CardiaCare)
Vivek Reddy, MD

AcuNav Lumos 4D ICE Workflow in Concomitant AF Ablation and LAAC Procedures (Siemens Healthineers)
Amin Al-Ahmad, MD

The Importance of Trigger Mapping in AF
(Vektor Medical)
Anish Amin, MD

Volta Medical and PFA - An Optimized Strategy for Repeat Catheter Ablations
(Volta Medical)
Devi Nair, MD

FDA Perspective on Evaluation of New Technologies for AF Ablation: A Changing Landscape
Jun Dong, MD

9:30-10:00 AM Break

10 AM-12:30 PM
Case Transmissions Session 1
Moderator: Moussa Mansour, MD
Panel: Claudio Tondo, MD, PhD, Roland Tilz, MD, Christopher Ellis, MD, Andrea Natale, MD, Devi Nair, MD, Vivek Reddy, MD, & Jacqueline Saw, MD

WATCHMAN Left Atrial Appendage Closure Using the TrueSteer Access System
Bradley Mikaelian, MD (Univ Colorado, Colorado Springs, CO)

Concomitant AF Ablation with Amulet LAAO
Dhanunjaya R. Lakkireddy, MD (Kansas City Heart Institute, Overland Park, KS)

Left Atrial Appendage Closure With the LAMINARLAA Device
Devi Nair, MD (St. Bernards Healthcare, Jonesboro, AR)

Concomitant Ablation of AF Using the FARAWAVE Pentaspline PFA Catheter and WATCHMAN LAA Closure
Rodney Horton, MD & Weeranun Bode, MD (Texas Cardiac Arrhythmia Institute, Austin, TX)

Elimination of the Left Atrial Appendage by Invagination and Ligation with a Novel Transcatheter System
Vivek Reddy, MD and Petr Neuzil, MD, PhD (Homolka Hospital, Prague, Czech Republic)

12:30-1:30 PM Lunch

1:30-2:30 PM
Case Transmissions Session 2
Moderator: Moussa Mansour, MD
Panel: Andrea Natale, MD, Andrea Russo, MD, Luigi Di Biase, MD, PhD, Tina Baykaner, MD, & Gerhard Hindricks, MD, PhD

Ablation of Paroxysmal AF Using the VARIPULSE Variable Loop Circular PFA Catheter
Dhanunjaya R. Lakkireddy, MD (Kansas City Heart Institute, Overland Park, KS)

Concomitant Ablation of PAF Using the VARIPULSE Variable Loop Circular PFA Catheter and LAA Closure Using NUVISION Guidance
Rodney Horton MD & Weeranun Bode, MD (Texas Cardiac Arrhythmia Institute, Austin, TX)

2:30-3:30 PM
Stroke Risk Management in Atrial Fibrillation Session I
Moderators: Daniel Singer, MD and Mina Chung, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Anticoagulation in Low Risk Patients with AF - Impact on Stroke on Cognitive Function
Lena Rivard, MD

Management of Device-Detected AF - Implications of ARTESIA and NOAH-AFNET 6 Trials
Andreas Rillig, MD

Current Status of Factor XIa Inhibitors for AF Post OCEANIC-AF Trial
Jonathan Piccini, MD, MHS

Anticoagulation Strategies After Left Atrial Appendage Closure 2025
Walid Saliba, MD

Stroke Prevention Following Catheter Ablation for AF: Patient Selection for LAA Closure - Insights from the OPTION Study
Oussama Wazni, MD

Panel and Audience Discussion (25 minutes) – All Faculty

3:30-4:30 PM
Stroke Risk Management in Atrial Fibrillation Session II
Supported by an Educational Grant from Boston Scientific
Moderators: Devi Nair, MD and Jacqueline Saw, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Procedural Methods to Avoid Leaks During Implantation with LAA Closure Devices 
Christopher Ellis, MD

Predictors of and Strategies for Avoiding Complications with LAA Closure Procedures
James Freeman, MD

ICE Guided LAA Closure - Extent of Use and Limitations
Shephal Doshi, MD

Future Directions in LAA Closure Devices and Enabling Technologies
Vivek Reddy, MD

Strategies for Accelerating Approval of Stroke Prevention Devices - Alternative Endpoints
Aneesh Deoras, MSE

Panel and Audience Discussion (25 minutes) - All Faculty

4:30 – 5:00 PM Break

Thursday continues >>>